Sterzyńska, K.; Kaźmierczak, D.; Klejewski, A.; Świerczewska, M.; Wojtowicz, K.; Nowacka, M.; Brązert, J.; Nowicki, M.; Januchowski, R.
Expression of Osteoblast-Specific Factor 2 (OSF-2, Periostin) Is Associated with Drug Resistance in Ovarian Cancer Cell Lines. Int. J. Mol. Sci. 2019, 20, 3927.
https://doi.org/10.3390/ijms20163927
AMA Style
Sterzyńska K, Kaźmierczak D, Klejewski A, Świerczewska M, Wojtowicz K, Nowacka M, Brązert J, Nowicki M, Januchowski R.
Expression of Osteoblast-Specific Factor 2 (OSF-2, Periostin) Is Associated with Drug Resistance in Ovarian Cancer Cell Lines. International Journal of Molecular Sciences. 2019; 20(16):3927.
https://doi.org/10.3390/ijms20163927
Chicago/Turabian Style
Sterzyńska, Karolina, Dominika Kaźmierczak, Andrzej Klejewski, Monika Świerczewska, Karolina Wojtowicz, Marta Nowacka, Jacek Brązert, Michał Nowicki, and Radosław Januchowski.
2019. "Expression of Osteoblast-Specific Factor 2 (OSF-2, Periostin) Is Associated with Drug Resistance in Ovarian Cancer Cell Lines" International Journal of Molecular Sciences 20, no. 16: 3927.
https://doi.org/10.3390/ijms20163927
APA Style
Sterzyńska, K., Kaźmierczak, D., Klejewski, A., Świerczewska, M., Wojtowicz, K., Nowacka, M., Brązert, J., Nowicki, M., & Januchowski, R.
(2019). Expression of Osteoblast-Specific Factor 2 (OSF-2, Periostin) Is Associated with Drug Resistance in Ovarian Cancer Cell Lines. International Journal of Molecular Sciences, 20(16), 3927.
https://doi.org/10.3390/ijms20163927
